tradingkey.logo

Applied DNA Sciences Inc

APDN

2.940USD

+0.070+2.44%
Close 09/19, 16:00ETQuotes delayed by 15 min
2.65MMarket Cap
LossP/E TTM

Applied DNA Sciences Inc

2.940

+0.070+2.44%

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite a strong stock market performance, the company shows strong fundamentals and technicals, which don't support the current strong trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
131 / 207
Overall Ranking
326 / 4720
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 1 analysts
Hold
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
Growing
The company is in a growing phase, with the latest annual income totaling USD 3.43M.
Overvalued
The company’s latest PE is 0.00, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 34.98K shares, decreasing 20.18% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 0.00 shares of this stock.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 5.88, which is lower than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 304.39K, representing a year-over-year decrease of 61.83%, while its net profit experienced a year-over-year decrease of 1134.45%.

Score

Industry at a Glance

Previous score
5.88
Change
0

Financials

9.18

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data

Quality of Earnings

7.50

Operational Efficiency

2.57

Growth Potential

3.04

Shareholder Returns

7.11

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 7.85, which is higher than the Healthcare Equipment & Supplies industry's average of 3.59. Its current P/E ratio is 0.00, which is -22025.00% below the recent high of -0.18 and 197353037.50% above the recent low of -1578.82.

Score

Industry at a Glance

Previous score
7.85
Change
1.2

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 131/207
No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

The company’s current earnings forecast score is 6.00, which is lower than the Healthcare Equipment & Supplies industry's average of 7.70.

Score

Industry at a Glance

Previous score
6.00
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 1 analysts
Hold
Current Rating
0.000
Target Price
0.00%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

118
Total
7
Median
8
Average
Company name
Ratings
Analysts
Applied DNA Sciences Inc
APDN
1
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
29
1
2
3
...
24

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 1.35, which is lower than the Healthcare Equipment & Supplies industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 3.76 and the support level at 2.06, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
1.35
Change
0

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(5)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
0.167
Neutral
RSI(14)
43.385
Neutral
STOCH(KDJ)(9,3,3)
41.679
Neutral
ATR(14)
0.329
Low Volatility
CCI(14)
57.332
Neutral
Williams %R
52.350
Neutral
TRIX(12,20)
-1.627
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
2.874
Buy
MA10
2.689
Buy
MA20
2.905
Buy
MA50
3.893
Sell
MA100
3.461
Sell
MA200
4.972
Sell

Institutional Confidence

Currency: USD Updated: 2025-09-19

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 6.73%, representing a quarter-over-quarter decrease of 80.68%. The largest institutional shareholder is The Vanguard, holding a total of 0.00 shares, representing 0.00% of shares outstanding, with 100.00% decrease in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Anson Funds Management LP.
4.57K
-67.39%
Sabby Management, LLC
6.97K
+22.64%
UBS Financial Services, Inc.
2.31K
--
Altium Capital Management LP
6.50K
--
S.H.N. Financial Investments Ltd
5.03K
--
Bigger (Michael)
5.00K
--
L1 Capital Global Opportunities Master Fund Ltd.
4.17K
--
Tower Research Capital LLC
32.00
+128.57%
SBI Securities Co., Ltd.
67.00
-57.32%
1
2

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 2.92, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 0.09. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
2.92
Change
0
Beta vs S&P 500 index
0.09
VaR
+10.91%
240-Day Maximum Drawdown
+98.26%
240-Day Volatility
+327.45%
Return
Best Daily Return
60 days
+9.32%
120 days
+1626.90%
5 years
+1626.90%
Worst Daily Return
60 days
-17.01%
120 days
-100.00%
5 years
-100.00%
Sharpe Ratio
60 days
-1.99
120 days
+1.20
5 years
+0.37
Risk Assessment
Maximum Drawdown
240 days
+98.26%
3 years
+99.98%
5 years
+100.00%
Return-to-Drawdown Ratio
240 days
-0.85
3 years
-0.33
5 years
-0.20
Skewness
240 days
+14.93
3 years
+25.39
5 years
+30.88
Volatility
Realised Volatility
240 days
+327.45%
5 years
+201.34%
Standardised True Range
240 days
+27.65%
5 years
+7067.74%
Downside Risk-Adjusted Return
120 days
+1050.60%
240 days
+1050.60%
Maximum Daily Upside Volatility
60 days
+135.08%
Maximum Daily Downside Volatility
60 days
+67.68%
Liquidity
Average Turnover Rate
60 days
+2.01%
120 days
+91.93%
5 years
--
Turnover Deviation
20 days
-99.93%
60 days
-99.89%
120 days
-95.16%

Peer Comparison

Healthcare Equipment & Supplies
Applied DNA Sciences Inc
Applied DNA Sciences Inc
APDN
4.89 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
Insulet Corp
PODD
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
STERIS plc
STERIS plc
STE
8.33 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Stevanato Group SpA
Stevanato Group SpA
STVN
8.24 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Abbott Laboratories
Abbott Laboratories
ABT
8.13 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Transmedics Group Inc
Transmedics Group Inc
TMDX
8.01 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI